The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

Zantac -- also known as ranitidine -- was a popular heartburn drug until 2020, when the Food and Drug Administration ordered it removed from pharmacy shelves because of a potential cancer risk. While ...

On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer ...

Drug maker GSK plc (GSK, GSK.L) confirmed Wednesday that it has reached two confidential settlements in cases filed in California ...

GSK announced on Wednesday that it has reached confidential settlements in two lawsuits filed in California State Court ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

(RTTNews) - Drug maker GSK plc (GSK, GSK.L) confirmed Wednesday that it has reached two confidential settlements in cases filed in California State Court against heartburn drug Zantac (ranitidine ...

COIMBATORE: The district health department and police launched a probe against an unregistered medical practitioner at ...

The litigation began after the U.S. Food and Drug Administration in 2020 asked manufacturers to pull the drug off the market over concerns that its active ingredient, ranitidine, could degrade ...

GSK plc (LSE/NYSE: LON:GSK), the global biopharma company, today announced the settlement of two legal cases related to its heartburn medication Zantac (ranitidine). The confidential settlements were ...

GSK plc (LSE/NYSE: GSK), the global biopharma company, today announced the settlement of two legal cases related to its heartburn medication Zantac (ranitidine). The confidential settlements were ...